GlobeNewsWire · ZNTL · October 18, 2026

Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract

Get the app for more

Explore stock news, insights and company research.